Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion.

作者: X Zhang , L Giangreco , H E Broome , C M Dargan , S L Swain

DOI: 10.1084/JEM.182.3.699

关键词:

摘要: The signals that determine the size and duration of primary T cell immune response are not well defined. We studied CD4 cells at an important checkpoint in their development: when they have become effectors ready to rapidly mediate effector functions, both via direct interaction with antigen (Ag)-presenting cytokine production. determined effects specific Ag cytokines interleukin (IL) 2 transforming growth factor (TGF) beta 1 on helper type (Th2) apoptosis versus expansion. Th2-polarized were generated vitro from naive receptor transgenic mice, then restimulated or without peptide plus Ag-presenting cytokines. In absence added cytokines, cultured died after 4-7 d. Paradoxically, induced proliferation high levels synthesis accelerated death. IL-2 directly effectors, supported prolonged Ag-induced proliferation, partially blocked apoptosis. TGF-beta did effect influence secretion, but it also Together, synergized almost completely block apoptosis, resulting expansion leading accumulation a large pool effectors. When present, population increased 10(4)-10(5) fold over 20 d culture. synergy suggests interfere programmed death by distinct mechanisms. Since Th2 specialized help B develop into antibody-secreting plasma cells, these results suggest availability is key influencing fate thus antibody response.

参考文章(22)
S L Swain, M Croft, Analysis of CD4+ T cells that provide contact-dependent bystander help to B cells. Journal of Immunology. ,vol. 149, pp. 3157- 3165 ,(1992)
O Janssen, D Kabelitz, S Wesselborg, Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells Journal of Immunology. ,vol. 150, pp. 4338- 4345 ,(1993)
Lisa L Lau, Beth D Jamieson, T Somasundaram, Rafi Ahmed, None, Cytotoxic T-cell memory without antigen Nature. ,vol. 369, pp. 648- 652 ,(1994) , 10.1038/369648A0
Harold L. Moses, Edmund Y. Yang, Jennifer A. Pietenpol, TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights Cell. ,vol. 63, pp. 245- 247 ,(1990) , 10.1016/0092-8674(90)90155-8
Harald von Boehmer, Positive selection of lymphocytes. Cell. ,vol. 76, pp. 219- 228 ,(1994) , 10.1016/0092-8674(94)90330-1
Susan L. Swain, Lymphokines and the immune response: the central role of interleukin-2 Current Opinion in Immunology. ,vol. 3, pp. 304- 310 ,(1991) , 10.1016/0952-7915(91)90028-Y
Jonathan Sprent, T and B memory cells. Cell. ,vol. 76, pp. 315- 322 ,(1994) , 10.1016/0092-8674(94)90338-7
A. Zentella, J. Massague, Transforming growth factor beta induces myoblast differentiation in the presence of mitogens Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 5176- 5180 ,(1992) , 10.1073/PNAS.89.11.5176
R L Coffman, D A Lebman, B Shrader, Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. Journal of Experimental Medicine. ,vol. 170, pp. 1039- 1044 ,(1989) , 10.1084/JEM.170.3.1039
Douglas R. Green, Artin Mahboubi, Walter Nishioka, Susan Oja, Fernantxj Echeverri, Yufang Shi, Jaqueline Glynn, Yili Yang, Jonathan Ashwell, Reid Bjssonnette, Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals. Immunological Reviews. ,vol. 142, pp. 321- 342 ,(1994) , 10.1111/J.1600-065X.1994.TB00895.X